HCPs see CGM as the 'standard of care': Half of all HCPs felt CGM should be the standard of care for people with Type 2 diabetes whether they were using insulin to manage the condition or not. 96% of ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Insulet Corporation (NASDAQ: PODD) has announced its plan to offer $450 million aggregate principal amount of senior ...

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new geographies.

AID system powered by Tidepool expected to launch Q2 2025 in the U.S. with Abbott’s FreeStyle Libre® 3 Plus sensorMANCHESTER, N.H., March 18, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company ...

Trua, a pioneer and leader in reusable, verified, digital trust credentials, announced today that 451 Research, a part of S&P Global Market Intelligence, published a new report on Trua, marking the ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada ...

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

Greenhawk Resources Inc. ("Greenhawk" or the "Company") is pleased to announce that it has agreed to terms for the amendment and restructuring of the existing $2,700,000 convertible debenture (the ...

A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...

There is a growing need for additional treatment options for individuals with type 2 diabetes who are being treated with ...